India

Krsnaa Diagnostics acquires 23.53% stake in Apulki Healthcare to expand cancer and cardiac care services

Synopsis

Krsnaa Diagnostics has announced the acquisition of a 23.53% stake in Apulki Healthcare, India's first public-private partnership for cancer and cardiac care hospitals. This strategic move aims to provide a comprehensive suite of integrated diagnostic services for patients. Yash Mutha, the joint managing director, highlighted the investment's significance in enhancing their position within the expanding healthcare sector. The funding will come entirely from internal accruals, ensuring no impact on cash flow. The collaboration will also cater to the rising demand for advanced diagnostics among urban retail patients.

10 sec backward button
play pause button
10 sec forward button
0:00
0:00

Integrated diagnostic services provider Krsnaa Diagnostics recently announced that it has acquired a 23.53% stake in Apulki Healthcare, India's first public-private partnership focused on cancer and cardiac care hospitals. This acquisition aims to offer a comprehensive suite of integrated diagnostic services for cancer and cardiac patients all in one location, as stated by the company. However, the details regarding the deal size were not disclosed.

Yash Mutha, the joint managing director of Krsnaa Diagnostics, stated that the investment was more than just a strategic partnership; it was a game changer for the Indian healthcare landscape. He mentioned that by acquiring a stake in Apulki, they were positioning themselves at the forefront of the rapidly growing cancer and cardiac care segment. Mutha added that the investment would be finalised upon meeting certain conditions, and the exact amount would be disclosed once the definitive documents were signed.

Mutha emphasised that this investment will not impact their cash flows, as it will be funded entirely through internal accruals over the next two to three months. He added that through this collaboration, they would not only support patients within the hospitals but also address the growing demand for advanced diagnostics among retail patients in urban areas.

In conclusion, the acquisition by Krsnaa Diagnostics marks a pivotal moment in the Indian healthcare landscape, positioning the company to address critical needs in cancer and cardiac care. By integrating diagnostic services under one roof, Krsnaa aims to improve patient outcomes while responding to the growing demand in urban areas. This initiative not only strengthens their market presence but also reinforces their commitment to enhancing healthcare accessibility and innovation in India.

Have something to say? Post your comment

Recent Messages

Advertisement